ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – BCLI
December 25, 2023 17:10 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between...
值得信賴的投資者法律顧問 ROSEN 鼓勵蒙受損失的 Brainstorm Cell Therapeutics Inc. 投資者在該所對 BCLI 首次提起集體訴訟的重要截止日期 1 月 2 日前聘請律師
December 25, 2023 17:10 ET
|
The Rosen Law Firm PA
紐約, Dec. 26, 2023 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律所 Rosen Law Firm 提醒於 2022 年 8 月 15 日至 2023 年 9 月 27 日期間（含上述兩日，簡稱「集體訴訟期」）購買 Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)...
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
December 24, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
December 22, 2023 11:11 ET
|
Pomerantz LLP
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline
December 21, 2023 13:21 ET
|
Levi & Korsinsky, LLP
NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Brainstorm Cell Therapeutics Inc. ("Brainstorm Cell" or the "Company") (NASDAQ: BCLI) of a class action...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)
December 21, 2023 12:14 ET
|
Glancy Prongay & Murray LLP
LOS ANGELES, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 2, 2024 deadline to file a lead plaintiff motion in the class action...
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
December 20, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 – (NASDAQ: BCLI)
December 20, 2023 12:31 ET
|
The Gross Law Firm
NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Brainstorm Cell Therapeutics Inc. Shareholders who purchased shares of BCLI during...
BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
December 20, 2023 10:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...
ROSEN, THE FIRST FILING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI
December 19, 2023 13:44 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between...